Dr. Dowell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615- Is this information wrong?
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1993 - 1996
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 1994 - 2025
TN State Medical License 1999 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Start of enrollment: 2006 Jun 01
- Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma Start of enrollment: 2006 Feb 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Ea...Wang, H., Shaverdashvili, K., Reyes, V., Mehta, D., Marsh, C., Waas, J., VanderWeele, R., Peracha, S., Liang, H., Socinski, M., Gerber, D., Dowell, J., Villaruz, L.> ;Eclinicalmedicine. 2023 Dec 1
- Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors.Mundra, V., Yang, Y., von Itzstein, M., Fattah, F., Gonugunta, A., Hannan, R., Pop, L., Zhang, Y., Wang, Y., Sheffield, T., Xie, Y., Dowell, J., Homsi, J., Rashdan, S....> ;Translational Oncology. 2023 Aug 1
- 4 citationsPhase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer.Sheena Bhalla, Farjana J Fattah, Chul Ahn, Jessica Williams, Alyssa Macchiaroli, Jonathan Padro, Meredith Pogue, Jonathan E Dowell, William C Putnam, Nigel McCracken, ...> ;Lung Cancer. 2023 Aug 1
- Join now to see all
Journal Articles
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesDavid E Gerber, Jonathan E Dowell, Clinical Lung Cancer
Authored Content
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesNovember 2018
Press Mentions
Medical Student Training to Tackle Health Disparities with Language Skills ProgramJuly 15th, 2021
Double-Drug Strategy Blocks Escape Route for Most Lung CancersApril 5th, 2018
Texas Researchers Summarize Promising Research on New Mesothelioma Drug, According to Surviving MesotheliomaMay 2nd, 2017
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Dallas VA North Texas HCSDallas, Texas- Dallas Veterans CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
